期刊文献+

关于ICU病房鲍曼不动杆菌耐药性及基因型研究 被引量:3

Resistance to Antimicrobial Agents and Investigation of the Encoded Genes of Acinetobacter Baumannii in ICU
下载PDF
导出
摘要 目的调查分析聊城地区ICU病房109株鲍曼不动杆菌耐药性及β-内酰胺酶基因型。方法用K-B法测定临床分离的109株鲍曼不动杆菌对13种抗菌药物的耐药性,采用PCR法检测β-内酰胺酶耐药基因型。结果除IMP外,109株鲍曼不动杆菌对其余13种抗菌药物的耐药率均超过50%,PCR扩增对IMP中介或耐药的53株鲍曼不动杆菌有11株扩增到blaOXA-23,产ESBLs组29株中有5株扩增出blasHv、blaCTX-M-14、blaCTX-M-3,2株出现blaSHV、blaCTX-M-1。结论聊城地区ICU病房鲍曼不动杆菌多重耐药常见,β-内酰胺酶产生率高,碳青霉烯酶以blaOXA-23型为主,ESBLs、AmpC酶两种β-内酰胺酶基因的多重PCR阳性率均低。 Objective To investigate and study the resistance and main genotypes of β-lactamases of 109 strains Acinetobacter baumannii in ICU of Liaocheng Region.Methods Kirby-Bauer method was performed to detect the resistance to thirteen kinds of antimicrobial agents against 109 strains of Acinetobacter baumannii which were collected from clinic,main genotypes of β-lactamases were assayed by PCR.Results In addition to IMP,the 109 Acinetobacter baumannii on the remaining 13 kinds of antimicrobial drug resistance rate of more than 50%,PCR amplification of the IMP intermediate or-resistant Acinetobacter baumannii 53 has 11 expanded to blaOXA-23,producing ESBLs group of 29 there are five amplified blasHv,blaCTX-M-14,blaCTX-M-3,2 strain of blaSHV,blaCTX-M-1.Conclusion In ICU of Liaocheng district multi-drug resistant Acinetobacter baumannii common,β-lactamase-producing rate high,Carbapenemases to blaOXA-23-type-based,ESBLs,AmpC enzymes two kinds of β-lactamase genes of multiple PCR positive rates are low.
作者 金红 曹银光
机构地区 聊城市人民医院
出处 《中国实验诊断学》 北大核心 2011年第7期1137-1140,共4页 Chinese Journal of Laboratory Diagnosis
关键词 鲍曼不动杆菌 Β-内酰胺酶 基因型 Acinetobacter baumannii β-lactamases genotype
  • 相关文献

参考文献7

  • 1Bou G, Cervero G, Dominguez MA, et al. Character ization of a nosocomial outbreakcaused by a multire sistant Acinetobacter baumannii strain with a carbap enem hydrolyzing enzyme:high level carbapenem resistance in A. baum annii is not due solely to the ores ence of β-lactamases[ J]. J Clin- Microbiol, 2000,38 : 3299.
  • 2Coudron PE, Moland ES, Thomoson KS. Occurrence and deteetion of Am- pC beta- lactamases among Escherichia coli, Klebiella Pneumoniae, and Protrus mirabilis isolates at a veteran' s medical center [ J]. J Clin micro- bid. 2000; 38 : 1791.
  • 3Jiang XF, Hong XI-I, Sun JY, et al. Analysis of beta-lactamase in multi- resistant Pseudomonas aeruginosa [ J ]. Chin J Microbiol Immunol, 2002, 22:443.
  • 4Via J, Marcos A, Marco F, et a l. In vitro antimicrobial produefio/1 of beta- lacramases, aminoglycoside modifying enzylnc8, and chloramphenicol acetyhran sferase and suscepfibilityof clinical isolates of acinetobacter banmanni[ j ]. Antimicrob AsentChemother, 1993,37 : 138.
  • 5朱旭慧,孙自镛,简翠,李丽,张蓓,申正义.不动杆菌属的耐药性分析[J].中国抗感染化疗杂志,2005,5(6):342-345. 被引量:37
  • 6张翊,卢建平.鲍氏不动杆菌感染及耐药性变化的趋势[J].中华医院感染学杂志,2004,14(3):341-343. 被引量:91
  • 7王春新,谢国强,严子禾,潘宇红,胡瑜.耐亚胺培南细菌的临床分离及耐药谱分析[J].国外医学(临床生物化学与检验学分册),2005,26(9):666-667. 被引量:8

二级参考文献19

  • 1Krcmery V Jr,Trup J,Kunova A, et al. Imipenem- resistant Ps.aeruginosa bacteraemia in cancer patients:risk factors,clinical features and outcome.Bratisl Lek Listy,1996,97(11):647-651.
  • 2Troillet N,Samore MH,Carmeli Y,et al. Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns.Clin Infect Dis,1997,25(5):1094-1098.
  • 3NCCLS. Performance standards for antimicrobial susceptibility testing;Ninth informational supplement. NCCLS Document M100-S9.1999,19.36-75.
  • 4Cisneros JM, Reyes MJ, Pachon J, et al.Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features[J].Clin Infect Dis, 1996, 22(6): 1026-1032.
  • 5Rodriguez BJ, Pascual A, Galvez J, et al.Acinetobacter baumannii bacteremia: clinical and prognostic features[J].Enferm Infect Microbiol Clin, 2003, 21(5): 242-247.
  • 6Ayan M, Durmaz R, Aktas E, et al.Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital[J].J Hosp Infect, 2003, 54(1): 39-45.
  • 7Donald HM, Scaife W, Amyes SG, et al.Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92[J].Antimicrob Agents Chemother, 2000, 44(1): 196-199.
  • 8Afzal-Shah M,Livermore DM.Worldwide emergence of carbapenem-resistant Acinetobacter spp[J].J Antimicrob Chemother,1998,41:576-577.
  • 9Brisse S,Milatovic D,Fluit AC,et al.Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp using automated ribotyping[J].J Clin microbial,2000,38:3636-3645.
  • 10Larson EL.Persistent carriage of gram-negative bacteria on hands[J].Am J Infect Control,1981,9:112-119.

共引文献123

同被引文献23

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部